Pathogenic and regulatory roles for B cells in experimental autoimmune encephalomyelitis
暂无分享,去创建一个
[1] A. Viola,et al. Self-antigen presentation by mouse B cells results in regulatory T-cell induction rather than anergy or clonal deletion. , 2011, Blood.
[2] N. Hellings,et al. Myelin-phagocytosing macrophages modulate autoreactive T cell proliferation , 2011, Journal of Neuroinflammation.
[3] R. Flavell,et al. Mice Lacking Endogenous IL-10–Producing Regulatory B Cells Develop Exacerbated Disease and Present with an Increased Frequency of Th1/Th17 but a Decrease in Regulatory T Cells , 2011, The Journal of Immunology.
[4] A. Cross,et al. Rituximab Therapy Reduces Organ-Specific T Cell Responses and Ameliorates Experimental Autoimmune Encephalomyelitis , 2011, PloS one.
[5] Avijit Ray,et al. A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis , 2011, Journal of Neuroimmunology.
[6] P. Parren,et al. Late B Cell Depletion with a Human Anti-Human CD20 IgG1κ Monoclonal Antibody Halts the Development of Experimental Autoimmune Encephalomyelitis in Marmosets , 2010, The Journal of Immunology.
[7] D. Danilenko,et al. B‐cell activation influences T‐cell polarization and outcome of anti‐CD20 B‐cell depletion in central nervous system autoimmunity , 2010, Annals of neurology.
[8] T. Tedder,et al. Regulatory B Cells (B10 Cells) and Regulatory T Cells Have Independent Roles in Controlling Experimental Autoimmune Encephalomyelitis Initiation and Late-Phase Immunopathogenesis , 2010, The Journal of Immunology.
[9] M. Mostarica‐Stojković,et al. Mechanisms of modulation of experimental autoimmune encephalomyelitis by chronic Trichinella spiralis infection in Dark Agouti rats , 2010, Parasite immunology.
[10] R. Maizels,et al. Helminth-induced CD 19 1 CD 23 hi B cells modulate experimental allergic and autoimmune inflammation , 2010 .
[11] Moses Rodriguez,et al. Cellular mechanisms of central nervous system repair by natural autoreactive monoclonal antibodies. , 2009, Archives of neurology.
[12] A. Waisman,et al. Nonredundant Roles for B Cell-Derived IL-10 in Immune Counter-Regulation1 , 2009, The Journal of Immunology.
[13] T. Tsubata,et al. The Development and Function of Regulatory B Cells Expressing IL-10 (B10 Cells) Requires Antigen Receptor Diversity and TLR Signals1 , 2009, The Journal of Immunology.
[14] K. Berer,et al. Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells , 2009, The Journal of experimental medicine.
[15] R. Geha,et al. Toll-like receptor 2 is important for the T(H)1 response to cutaneous sensitization. , 2009, The Journal of allergy and clinical immunology.
[16] Carl-Fredrik Flach,et al. B Lymphocytes Promote Expansion of Regulatory T Cells in Oral Tolerance: Powerful Induction by Antigen Coupled to Cholera Toxin B Subunit1 , 2008, The Journal of Immunology.
[17] M. Fujimoto,et al. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. , 2008, The Journal of clinical investigation.
[18] L. Qiao,et al. Resting B cells expand a CD4+CD25+Foxp3+ Treg population via TGF‐β3 , 2008, European journal of immunology.
[19] T. Lebien,et al. B lymphocytes: how they develop and function. , 2008, Blood.
[20] M. Fujimoto,et al. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. , 2008, Immunity.
[21] U. Steinhoff,et al. TLR-Activated B Cells Suppress T Cell-Mediated Autoimmunity1 , 2008, The Journal of Immunology.
[22] D. Arnold,et al. Rituximab in relapsing‐remitting multiple sclerosis: A 72‐week, open‐label, phase I trial , 2008, Annals of neurology.
[23] D. Arnold,et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. , 2008, The New England journal of medicine.
[24] A. Baxter,et al. The origin and application of experimental autoimmune encephalomyelitis , 2007, Nature Reviews Immunology.
[25] Wenda Gao,et al. Reciprocal generation of Th1/Th17 and Treg cells by B1 and B2 B cells , 2007, European journal of immunology.
[26] P. Jensen,et al. Cutting Edge: Primary B Lymphocytes Preferentially Expand Allogeneic FoxP3+ CD4 T Cells , 2007, The Journal of Immunology.
[27] S. Anderton,et al. The Inflamed Central Nervous System Drives the Activation and Rapid Proliferation of Foxp3+ Regulatory T Cells1 , 2007, The Journal of Immunology.
[28] S. Barnum,et al. Complement in experimental autoimmune encephalomyelitis revisited: C3 is required for development of maximal disease. , 2007, Molecular immunology.
[29] V. Kuchroo,et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation , 2007, Nature Medicine.
[30] Yanping Tan,et al. B Cell Regulation of CD4+CD25+ T Regulatory Cells and IL-10 Via B7 is Essential for Recovery From Experimental Autoimmune Encephalomyelitis1 , 2007, The Journal of Immunology.
[31] B. Becher,et al. Autoantibody-mediated demyelination depends on complement activation but not activatory Fc-receptors , 2006, Proceedings of the National Academy of Sciences.
[32] Loise M. Francisco,et al. Blockade of CTLA-4 on CD4+CD25+ Regulatory T Cells Abrogates Their Function In Vivo1 , 2006, The Journal of Immunology.
[33] M. Fujimoto,et al. Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response. , 2006, The American journal of pathology.
[34] L. A. Stephens,et al. Natural Recovery and Protection from Autoimmune Encephalomyelitis: Contribution of CD4+CD25+ Regulatory Cells within the Central Nervous System1 , 2005, The Journal of Immunology.
[35] A. Rudensky,et al. TGF-β1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells , 2005, The Journal of experimental medicine.
[36] Cheng-ming Sun,et al. Upon TLR9 signaling, CD5+ B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs. , 2005, Immunity.
[37] E. Frohman,et al. Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis. , 2005, Archives of neurology.
[38] S. Barnum,et al. Deletion of the Complement Anaphylatoxin C3a Receptor Attenuates, Whereas Ectopic Expression of C3a in the Brain Exacerbates, Experimental Autoimmune Encephalomyelitis1 , 2004, The Journal of Immunology.
[39] H. Rus,et al. Complement C5 in experimental autoimmune encephalomyelitis (EAE) facilitates remyelination and prevents gliosis. , 2003, The American journal of pathology.
[40] N. Ruddle,et al. Rat and Human Myelin Oligodendrocyte Glycoproteins Induce Experimental Autoimmune Encephalomyelitis by Different Mechanisms in C57BL/6 Mice1 , 2003, Journal of Immunology.
[41] S. Miller,et al. EncephalomyelitisExperimental Autoimmune System Inflammation During Active Immune Responses and Central Nervous Cells Suppress Antigen-Specific Autoreactive Regulatory T + CD25+ Cutting Edge: CD4 , 2022 .
[42] David Gray,et al. B cells regulate autoimmunity by provision of IL-10 , 2002, Nature Immunology.
[43] T. Takai. Roles of Fc receptors in autoimmunity , 2002, Nature Reviews Immunology.
[44] Michael J. Ramsbottom,et al. Critical role of antigen‐specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein , 2002, European journal of immunology.
[45] B. Hall,et al. Attenuation of Experimental Allergic Encephalomyelitis in Complement Component 6-Deficient Rats Is Associated with Reduced Complement C9 Deposition, P-Selectin Expression, and Cellular Infiltrate in Spinal Cords1 , 2002, The Journal of Immunology.
[46] D. Pham‐Dinh,et al. Pathological and regulatory effects of anti-myelin antibodies in experimental allergic encephalomyelitis in mice , 2002, Journal of Neuroimmunology.
[47] H. Lassmann,et al. The Membrane Attack Complex of Complement Causes Severe Demyelination Associated with Acute Axonal Injury1 , 2002, The Journal of Immunology.
[48] H. Lassmann,et al. Fc Receptors are Critical for Autoimmune Inflammatory Damage to the Central Nervous System in Experimental Autoimmune Encephalomyelitis , 2002, Scandinavian journal of immunology.
[49] M. Feldmann,et al. Different Therapeutic Outcomes in Experimental Allergic Encephalomyelitis Dependant Upon the Mode of Delivery of IL-10: A Comparison of the Effects of Protein, Adenoviral or Retroviral IL-10 Delivery into the Central Nervous System1 , 2001, The Journal of Immunology.
[50] E. Lavi,et al. Cutting Edge: C3, a Key Component of Complement Activation, Is Not Required for the Development of Myelin Oligodendrocyte Glycoprotein Peptide-Induced Experimental Autoimmune Encephalomyelitis in Mice1 , 2001, The Journal of Immunology.
[51] S. Swain,et al. Reciprocal regulation of polarized cytokine production by effector B and T cells , 2000, Nature Immunology.
[52] S. Barnum,et al. Attenuation of Experimental Autoimmune Demyelination in Complement-Deficient Mice1 , 2000, The Journal of Immunology.
[53] Shannon M. Anderson,et al. Germinal Center Initiation, Variable Gene Region Hypermutation, and Mutant B Cell Selection without Detectable Immune Complexes on Follicular Dendritic Cells , 2000, The Journal of experimental medicine.
[54] C. Janeway,et al. Relapsing and remitting experimental autoimmune encephalomyelitis in B cell deficient mice. , 2000, Journal of autoimmunity.
[55] J. Bluestone,et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. , 2000, Immunity.
[56] A. Cross,et al. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide , 1999, European journal of immunology.
[57] S. Amor,et al. The role of anti-myelin (auto)-antibodies in the phagocytosis of myelin by macrophages , 1999, Journal of Neuroimmunology.
[58] R. Merchant,et al. Evidence for Fas-dependent and Fas-independent mechanisms in the pathogenesis of experimental autoimmune encephalomyelitis. , 1999, Journal of immunology.
[59] R. Coffman,et al. Transgenic Interleukin 10 Prevents Induction of Experimental Autoimmune Encephalomyelitis , 1999, The Journal of experimental medicine.
[60] J. Fjell,et al. B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. , 1998, Journal of immunology.
[61] M. Fujimoto,et al. CD19 regulates B lymphocyte responses to transmembrane signals. , 1998, Seminars in immunology.
[62] H. Lassmann,et al. B Lymphocytes Producing Demyelinating Autoantibodies: Development and Function in Gene-targeted Transgenic Mice , 1998, Journal of Neuroimmunology.
[63] G. Stoll,et al. Time course and cellular localization of interleukin-10 mRNA and protein expression in autoimmune inflammation of the rat central nervous system. , 1998, The American journal of pathology.
[64] Charles A. Janeway,et al. Experimental Autoimmune Encephalomyelitis Induction in Genetically B Cell–deficient Mice , 1996, The Journal of experimental medicine.
[65] R. Schmidt,et al. Impaired IgG-Dependent Anaphylaxis and Arthus Reaction in FcγRIII (CD16) Deficient Mice , 1996 .
[66] M. Ono,et al. Augmented humoral and anaphylactic responses in FcγRII-deficient mice , 1996, Nature.
[67] N. Letvin,et al. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. , 1995, The Journal of clinical investigation.
[68] H. Lassmann,et al. Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis. , 1994, Journal of immunology.
[69] K. Mohler,et al. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. , 1992, Journal of immunology.
[70] D. Mason,et al. Development and follicular localization of tolerant B lymphocytes in lysozyme/anti-lysozyme IgM/IgD transgenic mice. , 1992, International immunology.
[71] H. Lassmann,et al. The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement , 1991, Journal of Neuroimmunology.
[72] Klaus Rajewsky,et al. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene , 1991, Nature.
[73] H. Lassmann,et al. Antibody‐mediated demyelination in experimental allergic encephalomyelitis is independent of complement membrane attack complex formation , 1991, Clinical and experimental immunology.
[74] J. Benjamins,et al. Opsonization of normal myelin by anti-myelin antibodies and normal serum , 1989, Journal of Neuroimmunology.
[75] H. Lassmann,et al. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. , 1988, The American journal of pathology.
[76] H. Weiner,et al. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. , 1987, Journal of immunology.
[77] H. Lassmann,et al. Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG) , 1987, Journal of Neuroimmunology.
[78] J. Trotter,et al. Opsonization with Antimyelin Antibody Increases the Uptake and Intracellular Metabolism of Myelin in Inflammatory Macrophages , 1986, Journal of neurochemistry.
[79] G. Danta,et al. Immunoglobulin deficient rats as donors and recipients of effector cells of allergic encephalomyelitis , 1986, Journal of Neuroimmunology.
[80] M. Webb,et al. A novel myelin-associated glycoprotein defined by a mouse monoclonal antibody , 1984, Journal of Neuroimmunology.
[81] D. Willenborg,et al. Immunoglobulin-deficient rats fail to develop experimental allergic encephalomyelitis , 1983, Journal of Neuroimmunology.
[82] P. Y. Paterson. TRANSFER OF ALLERGIC ENCEPHALOMYELITIS IN RATS BY MEANS OF LYMPH NODE CELLS , 1960, The Journal of experimental medicine.
[83] J. Freund,et al. The transfer of experimental allergic encephalomyelitis in the rat by means of parabiosis. , 1953, Journal of immunology.
[84] P. K. Olitsky,et al. EXPERIMENTAL DISSEMINATED ENCEPHALOMYELITIS IN WHITE MICE , 1949, The Journal of experimental medicine.
[85] H. Lassmann,et al. Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions , 2004, Acta Neuropathologica.
[86] E. Reinke,et al. Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. , 2003, International immunology.
[87] R. Coffman,et al. Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.
[88] H. Weiner,et al. IL-4-Deficient and Transgenic Mice Demonstrated by Studies of IL-10- and Autoimmune Encephalomyelitis as IL-10 Is Critical in the Regulation of , 1998 .
[89] R. Schmidt,et al. Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice. , 1996, Immunity.
[90] M. Ono,et al. Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice. , 1996, Nature.
[91] I. Cohen,et al. The rapid isolation of clonable antigen‐specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis , 1981, European journal of immunology.